motley-fool

3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015

Source: Celgene CorpBiotech stocks are notorious for their stratospheric gains and subterranean losses, especially clinical stage biotech stocks that develop promising, yet unproven, next-generation drugs. Those emerging biotech stocks may offer the potential for outsized returns, but they also carry significant risks. To help investors decide which of these clinical-stage companies may be worth considering in 2015, we asked three […]

Twitter's Favorite Biotech and Pharma Stocks

Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked ;the Twittersphere for their favorite drug stocks going into next year.
What’s your favorite stock for 2015 in biotech or Pharma?
– Mark Schoenebaum (@MarkSchoenebaum) December 12, 2014What was the top pick? A 21-way tie for first place. All 21 companies got a single vote.I kid you not. As I’m writing […]

3 Traits of the Best Healthcare Stocks in 2014

Source: MercK & Co.,Just when it looked as though the stock market couldn’t possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets’ historic annual return.But if you think that’s a solid return, […]

3 Biotech Stocks to Buy in December

Source: Biogen IdecAs the year begins to come to a close, biotechnology investors are right to wonder what stocks may be worth owning as we head into 2015. We asked three of our Motley Fool analysts to tell us which three biotechnology stocks will be in their stockings this holiday season. Read on to see which three companies they chose.Cheryl […]

Why Biotech Stocks Don't Pay Dividends

Dividend paying stocks are a staple in market-beating investment portfolios, but dividend investors don’t have very many options when it comes to investing in the biotechnology sector. Out of the largest biotechnology stocks, only Amgen has made the decision to reward investors with dividend payments.That’s likely frustrating to dividend investors. After all, biotech stocks like Gilead Sciences generate billions of […]

3 Biotech Stocks With Jaw-Dropping Growth Potential in 2015

The biotech industry has been absolutely soaring over the past two years, fueled by a rise in drug approvals, an merger-and-acquisition frenzy, and widespread reorganizations that have helped to mitigate the impact of the so-called “patent cliff.” Driving this point home, the closely watched iShares Nasdaq Biotechnology Index has appreciated a princely 162% since 2012:As earnings across the industry are […]

3 Biotech Stocks That Could Soar Even Higher

Source: ;Flickr user VastateparksstaffWhen to sell a winning stock is one of the toughest questions for investors to answer. Selling a stock that is reaching for new highs might be the right decision sometimes, but other times it might mean getting out of a long-haul opportunity too early. With that in mind, we asked three Motley Fool analysts to tell […]

3 Fast-Growing Biotech Stocks To Buy in December

Year end is coming up quickly, and that has investors pouring over portfolios, dissecting financial reports, and considering names to own heading into 2015. ;With that in mind, read on to learn why ;I think these three biotech stocks may prove worthy enough of investor wish-lists next month.Source: Cubist Pharmaceuticals1. Treating hospital infectionsOn December 21, the FDA will make a […]

Is your portfolio prepared for a stock market crash … – The Motley Fool

The world’s US$58.5 billion man, investor Warren Buffett, has for many years highlighted the benefits of holding large chunks of cash. Buffett, via his company Berkshire Hathaway often holds billions in cash simply to allow himself the optionality of seizing opportunities when they present themselves.Interestingly, it appears some of Australia’s top investors are currently following in Buffett’s footsteps and getting […]

Women With Children Shouldn't Trade Stocks (But They're Not the …

Alamy
Women with children should not trade stocks … at least, not according to Paul Tudor Jones.Last week, the billionaire founder of hedge fund management company Tudor Investment set the Internet rant-o-sphere on fire when a video of him speaking at an investment symposium at the University of Virginia leaked out.Paul Tudor Jones (Getty Images)
Among other impolitic statements caught […]